P

Inventor

MORIN PAUL E

US21 patents
⚠️ This page may combine multiple inventors who share the name “MORIN PAUL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

20 patents
US9434778B2Sep 6, 2016

Modified FGF-21 polypeptides comprising an internal deletion and uses thereof

BRISTOL MYERS SQUIBB CO31 citations97
US10406251B2Sep 10, 2019

PD-L1 binding polypeptides for imaging

BRISTOL MYERS SQUIBB CO15 citations92
US10189883B2Jan 29, 2019

Therapeutic uses of modified FGF-21 polypeptides

BRISTOL MYERS SQUIBB CO12 citations92
US9631004B2Apr 25, 2017

Modified FGF-21 polypeptides comprising an internal deletion and uses thereof

BRISTOL MYERS SQUIBB CO12 citations92
US9540424B2Jan 10, 2017

Serum albumin binding molecules

BRISTOL MYERS SQUIBB CO27 citations92
US10221438B2Mar 5, 2019

Serum albumin binding molecules

BRISTOL MYERS SQUIBB CO12 citations91
US11248031B2Feb 15, 2022

Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides

BRISTOL MYERS SQUIBB CO4 citations83
US10934572B2Mar 2, 2021

Serum albumin binding molecules

BRISTOL MYERS SQUIBB CO4 citations83
US10377806B2Aug 13, 2019

Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof

BRISTOL MYERS SQUIBB CO6 citations83
US10266578B2Apr 23, 2019

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

BRISTOL MYERS SQUIBB CO9 citations82
US11344639B2May 31, 2022

PET imaging with PD-L1 binding polypeptides

BRISTOL MYERS SQUIBB CO4 citations71
US11173219B2Nov 16, 2021

PD-L1 binding polypeptides for imaging

BRISTOL MYERS SQUIBB CO4 citations71
US12247058B2Mar 11, 2025

Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof

BRISTOL MYERS SQUIBB CO0 citations62
US12097242B2Sep 24, 2024

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

BRISTOL MYERS SQUIBB CO0 citations61
US12097241B2Sep 24, 2024

Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides

BRISTOL MYERS SQUIBB CO0 citations61
US11623965B2Apr 11, 2023

Prodruggable antibodies, prodrugs thereof, and methods of use and making

BRISTOL MYERS SQUIBB CO1 citations61
US11364281B2Jun 21, 2022

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof

BRISTOL MYERS SQUIBB CO0 citations61
US11185570B2Nov 30, 2021

Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides

BRISTOL MYERS SQUIBB CO0 citations61
US12194110B2Jan 14, 2025

PD-L1 binding polypeptides for imaging

BRISTOL MYERS SQUIBB CO0 citations60
US11623013B2Apr 11, 2023

Methods and compositions for deuterated biologics

BRISTOL MYERS SQUIBB CO0 citations57

GOSSELIN MICHAEL L

1 patent